Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kite Pharma Inc (KITE)

Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kite Pharma Inc 2225 COLORADO AVENUE SANTA MONICA CA 90404 USA

www.kitepharma.com P: 310-824-9999

Description:

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of cancer immunotherapy products. The Company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Kite Pharma, Inc. is headquartered in Santa Monica, California.

Key Statistics

Overview:

Market Capitalization, $K 10,314,552
Shares Outstanding, K 57,370
Annual Sales, $ 22,170 K
Annual Net Income, $ -267,070 K
Last Quarter Sales, $ 10,050 K
Last Quarter Net Income, $ -109,820 K
60-Month Beta 2.68
% of Insider Shareholders 14.00%
% of Institutional Shareholders 87.72%

Growth:

1-Year Return 226.72%
3-Year Return 452.18%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.50 on 08/08/17
Latest Earnings Date 11/08/17
Earnings Per Share ttm -6.87
EPS Growth vs. Prev Qtr -11.49%
EPS Growth vs. Prev Year -48.09%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KITE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.56%
Return-on-Assets % -48.86%
Profit Margin % -1,204.65%
Debt/Equity 0.00
Price/Sales 465.26
Price/Cash Flow N/A
Price/Book 14.33
Book Value/Share 12.54
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar